Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference

Core Insights - Lifecore Biomedical, Inc. will participate in the CDMO Live 2025 conference, a key event for the biopharma outsourcing industry, scheduled for May 7-8, 2025, in Rotterdam, Netherlands [1] - Jackie Klecker, Lifecore's executive vice president, will lead a discussion on transforming quality management into a strategic driver for CDMO partnerships, leveraging her 30 years of industry experience [2] Company Overview - Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) specializing in the development, fill, and finish of sterile injectable pharmaceutical products, including complex formulations [3] - The company has over 40 years of expertise in manufacturing premium, injectable-grade hyaluronic acid and serves global and emerging biopharmaceutical and biotechnology companies across various therapeutic categories [3]